Case report: Nitazoxanide for treatment of refractory bony hydatid disease

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 2, 2009, Pages 176-178

  Winning, Alison ^a   Braslins, Phillip ^a   McCarthy, James S ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; NITAZOXANIDE; PRAZIQUANTEL; ANTIPARASITIC AGENT; THIAZOLE DERIVATIVE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; COXITIS; CYST ASPIRATION; DISEASE COURSE; ECHINOCOCCOSIS; FEMALE; HIP RADIOGRAPHY; HUMAN; PELVIC INFLAMMATORY DISEASE; SOFT TISSUE; SURGICAL DRAINAGE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; BONE INFECTION; DRUG EFFECT; ECHINOCOCCUS GRANULOSUS; FATALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOLOGY; PELVIS; RADIOGRAPHY;

ANIMALIA; ECHINOCOCCUS MULTILOCULARIS;

AGED; ANIMALS; ANTIPARASITIC AGENTS; BONE DISEASES, INFECTIOUS; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; FATAL OUTCOME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PELVIS; THIAZOLES; TREATMENT OUTCOME;

EID: 59649116487     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.176     Document Type: Article

References (12)

1. Craig P, McManus D, Lightowlers M, Chabalgoity J, Garcia H, Gavidia C, Gilman R, Gonzalez A, Lorca M, Naquira C, Nieto A, Schantz P, 2007. Prevention and control of cystic echinococcosis. Lancet Infect Dis 7: 385-394.
2. McManus D, Zhang W, Li J, Bartley P, 2003. Echinococcosis. Lancet 362: 1295-1304.
3. Herrera A, Martinez A, 2003. Extraspinal bone hydatidosis. J Bone Joint Surg Am 85: 1790-1794.
4. Szypryt E, Morris D, Mulholland R, 1987. Combined chemotherapy and surgery for hydatid bone disease. J Bone Joint Surg Br 69: 141-144.
5. Walker M, Rossignol JF, Torgerson P, Hemphill A, 2004. In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. J Antimicrob Chemother 54: 609-616.
6. Bonifacino R, Dogliani E, Craig PS, 1997. Albendazole treatment and serological follow-up in hydatid disease of bone. Int Orthop 21: 127-132.
7. Hemphill A, Mueller J, Esposito M, 2006. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 7: 953-964.
8. Fox LM, Saravolatz LD, 2005. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 40: 1173-1180.
9. Korba BE, Montero AB, Farrar K, Gaye K, Mukerjee S, Ayers MS, Rossignol JF, 2008. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res 77: 56-63.
10. Stettler M, Fink R, Walker M, Gottstein B, Geary T, Rossignol JF, Hemphill A, 2003. In vitro parasiticidal effect of nitazoxanide against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother 47: 467-474.
11. Reuter S, Manfras B, Merkle M, Harter G, Kern P, 2006. In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob Agents Chemother 50: 2966-2970.
12. Stettler M, Rossignol JF, Fink R, Walker M, Gottstein B, Merli M, Theurillat R, Thorman W, Dricot E, Segers R, Hemphill A, 2004. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int J Parasitol 34: 615-624.